Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.62NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.82NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.20NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.22NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.38.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.79.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.47NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.7.18NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XAY.1.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.55NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BY.1.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EA.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XJNNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BR.5NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBF.8NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.1.29NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CM.5.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CM.8.1.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.60NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.9.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.15NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.6.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.1.35NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.45NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.31NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.160.26NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.39.1.2 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.4.15 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.75.10NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.36.21NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.1.23NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.134NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.39.1.3 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BN.1.3.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.1.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBC.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Q.2 (Alpha)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BL.1.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
M.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.82 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
A.30NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.36.35NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.23.1 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.466.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.60ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
BA.2.9.2ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
BA.2.11ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used